Trial Profile
Randomized, placebo-controlled, double-blind, parallel-group clinical study of GGS in patients with microscopic polyangiitis (MPA) (Phase 3 study)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Dec 2022
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Microscopic polyangiitis
- Focus Registrational; Therapeutic Use
- Sponsors Teijin Pharma
- 27 Dec 2021 Status changed from recruiting to completed.
- 01 May 2017 Planned End Date changed from 30 Sep 2016 to 30 Nov 2018.
- 06 Jun 2016 New trial record